Navigation Links
JCI table of contents: April 22, 2008
Date:4/22/2008

ein responsible for adding GalNAc-4-SO4 to the end of the carbohydrates on LH were found to have higher levels of LH in the blood than normal mice. In male mice this caused increased levels of testosterone and premature sexual development. In female mice this caused increased levels of estrogen, premature sexual development, and increased fertility. Thus, the authors concluded that the unique carbohydrate structures attached to LH have a crucial role in regulating the levels of this hormone in the blood.

TITLE: Ablation of GalNAc-4-sulfotranferase-1 enhances reproduction by altering the carbohydrate structures of luteinizing hormone in mice

AUTHOR CONTACT:
Jacques U. Baenziger
Washington University School of Medicine, St. Louis, Missouri, USA.
Phone: (314) 362-8730; Fax: (314) 362-8888; E-mail: baenziger@wustl.edu.

View the PDF of this article at: https://www.the-jci.org/article.php?id=32467


ONCOLOGY: Filling in the blanks: defining a molecular pathway that promotes inflammation and tumor development in the stomach

Persistent infection with the bacterium Helicobacter pylori leads to persistent inflammation of the stomach lining and in some individuals stomach cancer, also known as gastric cancer. New insight into some of the molecules and signaling pathways that might promote inflammation and tumor development in the stomach has been provided by a team of researchers in Australia, at the Royal Melbourne Hospital and Monash University, through their analysis of a mouse model of gastric cancer. Specifically, it was shown that the soluble factor IL-11 was responsible for promoting inflammation and tumor development in these mice through activation of the signaling molecules Stat3 and, to a lesser extent, Stat1. Further, the activation of Stat3 and Stat1 was found to induce the expression of more I
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
2. Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.
3. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
4. Tianyin Pharmaceutical Announces SFDA Approval to Market Azithromycin Dispersible Tablets
5. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
6. JCI online early table of contents: March 6, 2008
7. New 300mg Loading Dose Tablet for Plavix(R) Receives Positive Opinion From the European Committee for Medicinal Products (CHMP)
8. Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets
9. STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China
10. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
11. Beijing 2008 Olympic Games Vegetable Supplier Considering Kiwa as a Supplier of Bio-Fertilizers & Kiwa Announces CEO Interview with WallSt.net
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2008)... platform company has been built upon the foundati...patent that enables contemplative, synthetic brain...y of computational platforms. The emphasis of this...sagging Michigan economy through the creation of t...ed by these artificial minds. , ...
(Date:11/19/2008)...all/ -- Synvista Therapeutics, Inc. (AMEX: SYI ... the FDA has received its application for 510(k) c.... The 510(k) submission begins a 90-day review pr... the kit can be distributed to labs throughout the... "We are very pleased to announce the submission o...
(Date:11/19/2008)...stCall/ -- Jazz Pharmaceuticals,Inc. (Nasdaq: ...te presentation,planned for today at the Lazard C...ue to the proximity of the release of preliminary ...inical trial of JZP-6 (sodium oxybate) for,the tr...cipates that it will release the preliminary top-l...
(Date:11/19/2008)...e first and only FDA-approved once-daily amoxicill...TOWN, Md., Nov. 19 Middl...day announced it has hired the following key comme...nk L. Koos has joined MiddleBrook Pharmaceuticals ...elopment. Koos brings nearly 20 years, experience...
Breaking Biology Technology:Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics 2Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics 3Michigan Company Founded upon What Could Be History's Most Important Breakthrough in AI and Robotics 4Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit 2MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 2MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 3MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 4MiddleBrook Pharmaceuticals Hires Key Commercial Team Members 5
...sin attracts far fewer defense research dollars an...t a number of public and private initiatives are q...-tech national security projects. , ,These project...terrorism unfolds and the nation responds to the u...e Wisconsin Technology Council , believes there i...
... development in the United States is the National...ng in grant money by states. The NIH,s annual budg...vities in its own institutions in the Washington, ...nstitute (NCI) and the National Institute for Al... there are 27 different institutions - but funds m...
...e, as part of a directive to provide $5 million in...l research, has announced the state will provide $...o-founded by stem cell researcher James Thomson. ,...rofessor who first isolated human embryonic stem c...d Cellular Dynamics International . , ,The former...
...gy Inc. , the company whose automated computer sys...extending its market reach with a new acquisition....ment solutions provider based here, acquired Equi... management software vendor early this week. , ,"E...combined enterprises will result in a stronger pre...
Other Biology Technology:Chippewa Valley firms land more defense work 2Chippewa Valley firms land more defense work 3Chippewa Valley firms land more defense work 4Chippewa Valley firms land more defense work 5Chippewa Valley firms land more defense work 6Chippewa Valley firms land more defense work 7NIH '05 funding: Midwest has two states in Top 10 2NIH '05 funding: Midwest has two states in Top 10 3NIH '05 funding: Midwest has two states in Top 10 4NIH '05 funding: Midwest has two states in Top 10 5State puts up $1 million for James Thomson's new stem cell startup 2State puts up $1 million for James Thomson's new stem cell startup 3Eagle Technology acquires some synergy 2
(Date:11/19/2008)...STON -- (Nov. 19, 2008) -- Rice University scienti...tubborn pollutant TCE have created a method that l... of a catalyst as individual chemical bonds are fo... the bonds between the atoms of our molecules," sa...hese vibrations change frequency and intensity wit...
(Date:11/19/2008)...world,s largest alliance on agricultural research ...nmental scientists, policy makers and donor repres...008 to discuss the best approaches for meeting the...have shaken the global food system to its coreclim...costs and an explosive worldwide financial crisis....
(Date:11/19/2008)... first tissue-engineered trachea (windpipe), utili...sfully transplanted into a young woman with a fail...provided the patient with a normally functioning a...ble results provide crucial new evidence that adul...e materials, can offer genuine solutions to other ...
(Date:11/19/2008)... of the most reliable indicators to predict that a...ce of insulin resistance. Insulin is produced in t...uring that glucose reaches several tissues and org...ce is characterized by the lack of tissue response...ction of insulin by the pancreas. When the pancrea...
Breaking Biology News(10 mins):Researchers shed new light on catalyzed reactions 2Researchers shed new light on catalyzed reactions 3Major conference on food Dec. 1-2, 2008 2Adult stem cell breakthrough 2Adult stem cell breakthrough 3Researchers at IRB Barcelona produce more data on key genes in diabetes 2Researchers at IRB Barcelona produce more data on key genes in diabetes 3Binex and MaxCyte Collaborate on Cancer Immunotherapy Research 2030 1Binex and MaxCyte Collaborate on Cancer Immunotherapy Research 2030 2Albemarle Raises Prices of Specialty Aluminas 7320 1Albemarle Raises Prices of Specialty Aluminas 7320 2Pelosi Statement on World AIDS Day 7317 1Pelosi Statement on World AIDS Day 7317 2Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services 7314 1Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services 7314 2
...stop to consider the consequences of their daily a...lawns, and the flush of a toilet. However, wastew...civilization--is the largest microbially-mediated ...s, it is a microbial symphony in tune with humanit...Researchers from the U.S. Department of Energy Joi...
...archers at the University of Southern California h...an enzyme family that, through its ability to muta..., Reporting in the Dec. 24 online edition of Natur...unusual" crystal structure of the Apo2 enzyme. ...rst mechanistic analysis of any of the APOBEC enzy...
...he first experiments of their kind, researchers at... Anderson Cancer Center have determined that carbo... of research lab animals cause no immediate advers...our before they are removed by the liver. , The fi...chemically unmodified carbon nanotubes, a revoluti...
... of Takesha Henderson,s discoveries are named Char... entomology. Her graduate studies at Texas A&M...iders in Brazos County and one species found for t... the National Science Foundation, Henderson, who i...und spider diversity, distribution and abundance i...
Other Biology News:Better sludge through metagenomics 2Better sludge through metagenomics 3Better sludge through metagenomics 4USC team reveals structure of APOBEC family protein 2Pure carbon nanotubes pass first in vivo test 2Ground spider diversity studied in research project 2
Pyrophosphate Fluorometric (Blue) Assay Kit, EnzChek® from Molecular Probes (Invitrogen)
Human VEGF R2 (KDR) MAb (Clone 89106)
X-Gal from Research Organics, Inc.
Clone/PAD: ZMD.366. Immunogen: Synthetic peptide derived from an internal region of human SENP1. Specificity: Specific for the human ~73 kDa SENP1. Reactivity: Human (positive controls: (DYKDDDK o
Biology Products: